quantisnow
FeedTopReportsPricing
⌘K
Live feed
08:26:15·91d
ANALYSTRating
Legend Biotech Corporation logo

Legend Biotech downgraded by TD Cowen with a new price target

LEGN· Legend Biotech Corporation
Health Care
Original source

Companies

  • LEGN
    Legend Biotech Corporation
    Health Care

Recent analyst ratings

  • Feb 12UpdateRothschild & Co Redburn$24.00
  • Jan 22UpdateTD Cowen$21.00
  • Jan 7UpdateOppenheimer$75.00
  • Oct 7UpdateCantor Fitzgerald$40.00
  • Oct 8UpdateRedburn Atlantic$86.00
  • Jun 17UpdateTruist$88.00

Related

  • SEC9d
    SEC Form 6-K filed by Legend Biotech Corporation
  • INSIDER27d
    SEC Form 4 filed by Huang Ying
  • SEC28d
    SEC Form 144 filed by Legend Biotech Corporation
  • INSIDER36d
    SEC Form 3 filed by new insider Heyman Tomas J.
  • INSIDER36d
    SEC Form 3 filed by new insider Meng Robin
  • INSIDER36d
    SEC Form 3 filed by new insider Salovey Peter
  • INSIDER36d
    SEC Form 3 filed by new insider Casey Patrick John
  • INSIDER36d
    SEC Form 3 filed by new insider Kung Gareth
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022